ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction

Journal of Applied Physiology

Volumn 101, Issue 2, 2006, Pages 385-391

  Zoll, Joffrey ^a,d   Monassier, Laurent ^b   Garnier, Anne ^c   N'Guessan, Benoit ^a   Mettauer, Bertrand ^a   Veksler, Vladimir ^c   Piquard, François ^a   Ventura Clapier, Renée ^c   Geny, Bernard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Angiotensin converting enzyme inhibition; Mitochondria; Rehabilitation

Indexed keywords

CALCINEURIN; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTAMIC ACID; GLYCEROL; MALIC ACID; MITOCHONDRIAL CYTOCHROME C OXIDASE; NUCLEAR FACTOR; PERINDOPRIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN MITOCHONDRIAL TRANSCRIPTION FACTOR A; PYRUVIC ACID; SAPONIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BLOOD PRESSURE; CELL DAMAGE; CELL METABOLISM; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME INHIBITION; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; MYOPATHY; NONHUMAN; OXIDATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL;

EID: 33746714417     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01486.2005     Document Type: Article

References (33)

1. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX, and Ventura-Clapier R. Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 96: 59-64, 2004.
2. De Sousa E, Lechene P, Fortin D, N'Guessan B, Belmadani S, Bigard X, Veksler V, and Ventura-Clapier R. Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity. Cardiovasc Res 56: 260-268, 2002.
3. De Sousa E, Veksler V, Bigard X, Mateo P, and Ventura-Clapier R. Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102: 1847-1853, 2000.
4. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, and Ventura-Clapier R. Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 85: 68-76, 1999.
5. Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, and Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 79: 491-502, 1989.
6. Drexler H, Riede U, Munzel T, Konig H, Funke E, and Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759, 1992.
7. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, and Weber M. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 88: 1L-20L, 2001.
8. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, and Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551: 491-501, 2003.
9. Garnier A, Fortin D, Zoll J, N'Guessan B, Mettauer B, Lampert E, Veksler V, and Ventura-Clapier R. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J 19: 43-52, 2005.
10. Handschin C, Rhee J, Lin J, Tarr PT, and Spiegelman BM. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci USA 100: 7111-7116, 2003.
11. Hood DA. Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 90: 1137-1157, 2001.
12. Hugel S, Horn M, de Groot M, Remkes H, Dienesch C, Hu K, Ertl G, and Neubauer S. Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction. Am J Physiol Heart Circ Physiol 277: H2167-H2175, 1999.
13. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, and Spiegelman BM. Transcriptional coactivator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801, 2002.
14. Massie BM, Simonini A, Sahgal P, Wells L, and Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27: 140-145, 1996.
15. Mettauer B, Zoll J, Sanchez H, Lampert E, Ribera F, Veksler V, Bigard X, Mateo P, Epailly E, Lonsdorfer J, and Ventura-Clapier R. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 38: 947-954, 2001.
16. Momken I, Kahapip J, Bahi L, Badoual T, Hittinger L, Ventura-Clapier R, and Veksler V. Does angiotensin-converting enzyme inhibition improve the energetic status of cardiac and skeletal muscles in heart failure induced by aortic stenosis in rats? J Mol Cell Cardiol 35: 399-407, 2003.
17. Mulder P, Elfertak L, Richard V, Compagnon P, Devaux B, Henry JP, Scalbert E, Desche P, Mace B, and Thuille ZC. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol Heart Circ Physiol 271: H469-H477, 1996.
18. N'Guessan B, Zoll J, Ribera F, Ponsot E, Lampert E, Ventura-Clapier R, Veksler V, and Mettauer B. Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles. Mol Cell Biochem 256-257: 267-280, 2004.
19. Ponsot E, Zoll J, N'Guessan B, Ribera F, Lampert E, Richard R, Veksler V, Ventura-Clapier R, and Mettauer B. Mitochondrial tissue specificity of substrates utilization in rat cardiac and skeletal muscles. J Cell Physiol 203: 479-486, 2005.
20. Sanbe A, Tanonaka K, Kobayasi R, and Takeo S. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol 27: 2209-2222, 1995.
21. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576: 1-14, 2002.
22. Schieffer B, Wollert KC, Berchtold M, Saal K, Schieffer E, Hornig B, Riede UN, and Drexler H. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 269: H1507-H1513, 1995.
23. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, and Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 79: 128-136, 1996.
24. Sullivan MJ, Duscha BD, Klitgaard H, Kraus WE, Cobb FR, and Saltin B. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc 29: 860-866, 1997.
25. Teerlink JR and Clozel JP. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am J Physiol Heart Circ Physiol 264: H2111-H2118, 1993.
26. Ventura-Clapier R, De Sousa E, and Veksler V. Metabolic myopathy in heart failure. News Physiol Sci 17: 191-196, 2002.
27. Ventura-Clapier R, Garnier A, and Veksler V. Energy metabolism in heart failure. J Physiol 555: 1-13, 2004.
28. Williams AD, Selig S, Hare DL, Hayes A, Krum H, Patterson J, Geerling RH, Toia D, and Carey MF. Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J Card Fail 10: 141-148, 2004.
29. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, and Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124, 1999.
30. Yamaguchi F, Kawana K, Tanonaka K, Kamano I, Igarashi T, Gen E, Fujimoto Y, Maki T, Sanbe A, Nasa Y, and Takeo S. Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril. Br J Pharmacol 126: 1585-1592, 1999.
31. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, and Williams RS. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87: E61-E68, 2000.
32. Zoll J, N'Guessan B, Ribera F, Lampert E, Fortin D, Veksler V, Bigard X, Geny B, Lonsdorfer J, Ventura-Clapier R, and Mettauer B. Preserved response of mitochondrial function to short-term endurance training in skeletal muscle of heart transplant recipients. J Am Coll Cardiol 42: 126-132, 2003.
33. Zoll J, Sanchez H, N'Guessan B, Ribera F, Lampert E, Bigard X, Serrurier B, Fortin D, Geny B, Veksler V, Ventura-Clapier R, and Mettauer B. Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 543: 191-200, 2002.